StudyID,Drug_Name,Arm_ID,Date_End,Results_Posted_Or_Updated_Date,Study_Status,Outcome,Termination,No_Amendment,No_Substan_Amend,No_Sub_Screen,No_Sub_Enroll,Screen_Failure,Reasons_Screen_Fail,Enroll_Rate,Time_FPI,Prop_Center_Enroll_Target,Completer,Withdrawer,Discont_AE,Discont_LE,Loss_FU,Protocol_Viol,Treat_Adherence,Visit_Adherence,Assess_Adherence,Med_Treat,Med_Follow_Up,Discont,Med_Discont,Missing_All,Missing_PE,Missing_Key_SE,Med_Age,Min_Age,Max_Age,Prop_NA,Prop_AP,Prop_EU,Prop_AF,Prop_White,Prop_Asian,Prop_Black,Prop_Male,Heter_Index,Prop_Renal,Prop_Hepatic,Prop_HighRisk,Line0,Line1,Line2,Line3,Lapsed,Refractory,Prop_ECOG0,Prop_ECOG1,Prop_ECOG2,Prop_ECOG3,TEAEs,TRAEs,SAEs,Grade34_TEAEs,Grade34_TRAEs,AE_Spec,Inc_TEAES,Inc_Grade34_TEAEs,Grade34_Lab,Death_rate,No_Dosage,Dosage_Level,Dosing_Frequency,Cycle_Length,Formulation,group_id_raw,group_title_raw,group_desc_raw,N_group,count_male,count_female,count_white,count_black,count_asian,count_other,Missing_K
NCT00387465,Azacitidine 30mg/m2; Entinostat,NCT00387465_A1,November 2014,"May 9, 2019",Completed,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,18,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B2,Phase I - 30mg/m2 Azacitidine,Patients receive Azacitidine 30mg/m2 SQ and entinostat 7mg PO on days 3 and 10 of each cycle.,3,3,0,,,,,8
NCT00387465,Entinostat; Azacitidine 40mg/m2,NCT00387465_A2,November 2014,"May 9, 2019",Completed,,,,,,7,,,,,,,,,,,,,,,,,,,,,,,18,,1,,,,,,,0.4286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B3,Phase I - 40mg/m2 Azacitidine,Patients receive azacitidine 40mg/m2 SQ and entinostat 7mg PO on days 3 and 10 of each cycle.,7,3,4,,,,,8
NCT00387465,Entinostat; Azacitidine 40mg/m2,NCT00387465_A3,November 2014,"May 9, 2019",Completed,,,,,,35,,,,,,,,,,,,,,,,,,,,,,,18,,1,,,,,,,0.4857,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B1,Phase II Arm,Patients receive azacitidine 40mg/m2 subcutaneously (SQ) on days 1-6 and 8-10 and entinostat 7mg PO on days 3 and 10. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity.,35,17,18,,,,,8
NCT00387465,,NCT00387465_B4,November 2014,"May 9, 2019",Completed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B4,Total,Total of all reporting groups,,,,,,,,11
